CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0926-2020.
FDA sample analysis of Calci-Max lot 31453 showed the product zinc content to be 0.0% of label claim.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0926-2020.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Alfa Vitamins Laboratories, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0926-2020.
Alfa Vitamins Laboratories, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Alfa Vitamins Laboratories, Inc. Recall FAQ
Alfa Vitamins Laboratories, Inc. is the subject of a supplements safety report: CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL. The notice was published on March 24, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 1,877 units are potentially affected.